News

May 12, 2022
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
May 12, 2022
May 04, 2022
Mindset Pharma to Participate in Upcoming Conferences in May 2022
Mindset Pharma to Participate in Upcoming Conferences in May 2022
May 04, 2022
Apr 19, 2022
Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT and 5-MeO-DMT Drug Candidate Compounds
Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT and 5-MeO-DMT Drug Candidate Compounds
Apr 19, 2022
Apr 05, 2022
Mindset Pharma to Participate in Upcoming Conferences in April 2022
Mindset Pharma to Participate in Upcoming Conferences in April 2022
Apr 05, 2022
Mar 17, 2022
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders
Mar 17, 2022
Mar 03, 2022
Mindset Pharma to Participate in Upcoming Investor Conferences in March 2022
Mindset Pharma to Participate in Upcoming Investor Conferences in March 2022
Mar 03, 2022
Feb 17, 2022
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
Feb 17, 2022
Feb 08, 2022
Mindset Pharma Appoints Dr. Fiona Randall as Senior Vice President of External Alliances and Scientific Strategy
Mindset Pharma Appoints Dr. Fiona Randall as Senior Vice President of External Alliances and Scientific Strategy
Feb 08, 2022
Feb 03, 2022
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its “Microdosing” Compounds
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its “Microdosing” Compounds
Feb 03, 2022
Jan 25, 2022
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014
Jan 25, 2022
Jan 05, 2022
The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic Medicines
The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic Medicines
Jan 05, 2022
Jan 04, 2022
Mindset to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022
Mindset to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022
Jan 04, 2022
Subscribe for latest news